You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

C15.378.190.625

Showing 1 - 25 of 4,113
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Sarcoidosis Trial in Worldwide (CMK389, Placebo)

Recruiting
  • Pulmonary Sarcoidosis
  • Birmingham, Alabama
  • +27 more
Nov 2, 2022

Atopic Dermatitis Trial in Worldwide (LY3454738, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Fort Smith, Arkansas
  • +55 more
Jun 12, 2023

Chronic Hand Eczema Trial in Worldwide (Delgocitinib cream, Cream vehicle)

Completed
  • Chronic Hand Eczema
  • Delgocitinib cream
  • Cream vehicle
  • Brussels, Belgium
  • +49 more
Jan 6, 2023

Generalized Myasthenia Gravis Trial in Worldwide (ARGX-113)

Completed
  • Generalized Myasthenia Gravis
  • ARGX-113
  • Carlsbad, California
  • +51 more
Jul 8, 2022

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Contrast Enhancement in Magnetic Resonance Imaging, Non-central Nervous System Pathology Trial in Worldwide (Gadoquatrane

Not yet recruiting
  • Contrast Enhancement in Magnetic Resonance Imaging
  • Non-central Nervous System Pathology
  • Gadoquatrane (BAY1747846)
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jun 25, 2023

Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo)

Active, not recruiting
Has Results
  • Atopic Dermatitis
  • Caba, Buenos Aires, Argentina
  • +184 more
Jun 7, 2022

Psoriasis Trial in Worldwide (Ustekinumab, ABP 654)

Active, not recruiting
  • Psoriasis
  • Hot Springs, Arkansas
  • +87 more
Nov 4, 2022

Schizophrenia Trial in Worldwide (BI 425809, Placebo)

Recruiting
  • Schizophrenia
  • Garden Grove, California
  • +102 more
Jan 27, 2023

Cervical Cancer Trial in Worldwide (Tiragolumab, Atezolizumab)

Active, not recruiting
  • Cervical Cancer
  • Phoenix, Arizona
  • +65 more
Jan 19, 2023

Chronic Hand Eczema Trial in Worldwide (Delgocitinib)

Enrolling by invitation
  • Chronic Hand Eczema
  • Brussel, Belgium
  • +75 more
Apr 1, 2022

Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)

Completed
Has Results
  • Pneumococcal Infections
  • V114
  • +2 more
  • Palo Alto, California
  • +51 more
Sep 23, 2022

Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

Recruiting
  • Lymphoma, Mantle Cell
  • Downey, California
  • +231 more
Jan 16, 2023

Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Scottsdale, Arizona
  • +139 more
Sep 9, 2022

COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Mobile, Alabama
  • +199 more
Aug 10, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (CC-92480, Carfilzomib, Dexamethasone)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +130 more
Jan 27, 2023

Autoimmunity, Inflammation Trial in Worldwide (Secukinumab s.c. injection)

Recruiting
  • Autoimmunity, Inflammation
  • Secukinumab s.c. injection
  • Fullerton, California
  • +93 more
Jul 14, 2022

Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (lenalidomide, Placebo, Rituximab)

Completed
Has Results
  • Lymphoma, Large B-Cell, Diffuse
  • Fayetteville, Arkansas
  • +431 more
Nov 17, 2022

COPD (COPD), Chronic Bronchitis Trial in Worldwide (MEDI3506, Placebo)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Bronchitis
  • MEDI3506
  • Placebo
  • Sheffield, Alabama
  • +125 more
Jul 28, 2022

Spondyloarthritis Trial in Worldwide (Golimumab, Placebo)

Completed
  • Spondyloarthritis
  • Golimumab
  • Placebo
  • Brno, Czechia
  • +70 more
Jan 12, 2022

Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)

Active, not recruiting
Has Results
  • Uveal Melanoma
  • IMCgp100
  • +3 more
  • Los Angeles, California
  • +55 more
Mar 10, 2022

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Teclistamab, Pomalidomide, Bortezomib)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Berkeley, California
  • +188 more
Jan 27, 2023

Epilepsy Trial in Worldwide (Placebo, Brivaracetam, Antiepileptic drugs with market authorization available per country)

Completed
Has Results
  • Epilepsy
  • Placebo
  • +2 more
  • Phoenix, Arizona
  • +206 more
Jul 14, 2022

Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)

Not yet recruiting
  • Multiple Myeloma
  • idecabtagene vicleucel
  • +3 more
  • Gilbert, Arizona
  • +107 more
Sep 26, 2023

LMNA-Related Dilated Cardiomyopathy Trial in United States (ARRY-371797, p38 inhibitor, oral)

Completed
Has Results
  • LMNA-Related Dilated Cardiomyopathy
  • ARRY-371797, p38 inhibitor, oral
  • Aurora, Colorado
  • +3 more
Mar 3, 2022